Groowe Groowe / Newsroom / MAIA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MAIA News

MAIA Biotechnology, Inc.

Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)

globenewswire.com
MAIA

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

globenewswire.com
MAIA

MAIA Biotechnology Announces $1.51 Million Private Placement

globenewswire.com
MAIA

MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates

globenewswire.com
MAIA

MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer

globenewswire.com
MAIA

MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential

globenewswire.com
MAIA

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach

globenewswire.com
MAIA MRK

MAIA Biotechnology Announces Open Market Purchases by CEO and Directors

globenewswire.com
MAIA

MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025

globenewswire.com
MAIA

MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation

globenewswire.com
MAIA